Curative Biosciences (Curative Biosciences) EV-to-EBIT : -0.09 (As of May. 27, 2024)

Curative Biosciences EV-to-EBIT Chart

Curative Biosciences Annual Data
	Trend	Jun08	Jun09	Jun10	Jun11	Jun12	Jun13	Jun14	Jun15	Jun16	Jun17
EV-to-EBIT		Get a 7-Day Free Trial					-1.40	-28.91	-5.94	-3.97	-33.17

Curative Biosciences Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18
EV-to-EBIT	Get a 7-Day Free Trial															-6.41	-33.17	-119.53	-10.24	-8.94

Competitive Comparison of Curative Biosciences's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Curative Biosciences's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curative Biosciences's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curative Biosciences's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Curative Biosciences's EV-to-EBIT falls into.

Curative Biosciences EV-to-EBIT Calculation

Curative Biosciences's EV-to-EBIT for today is calculated as:

Curative Biosciences's current Enterprise Value is $0.05 Mil.
Curative Biosciences's EBIT for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curative Biosciences  (OTCPK:CBDX) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Curative Biosciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2018 is calculated as:

Curative Biosciences's Enterprise Value for the quarter that ended in Mar. 2018 was $4.64 Mil.
Curative Biosciences's EBIT for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curative Biosciences EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Curative Biosciences's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Curative Biosciences (Curative Biosciences) Business Description